Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stathmin 1 pseudogene 2 (STMN1P2) is a non-protein-coding pseudogene related to stathmin 1 (STMN1), a well-characterized protein involved in microtubule dynamics and cell cycle regulation[1][3]. Pseudogenes such as STMN1P2 do not encode functional proteins and are not considered therapeutic targets. While functional stathmin proteins regulate microtubule stability and play roles in cancer and cell division, pseudogenes are typically remnants of gene duplication or mutation and do not contribute directly to cellular function or disease mechanisms[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stathmin 1 pseudogene 2 (STMN1P2).